المؤلفون: Francesco Plotti, Stella Capriglione, Corrado Terranova, Roberto Montera, Alessia Aloisi, Patrizio Damiani, Giuseppe Scaletta, Roberto Angioli, MUZII, LUDOVICO, BENEDETTI PANICI, PIERLUIGI

المساهمون: Francesco, Plotti, Stella, Capriglione, Corrado, Terranova, Roberto, Montera, Alessia, Aloisi, Patrizio, Damiani, Muzii, Ludovico, Giuseppe, Scaletta, BENEDETTI PANICI, Pierluigi, Roberto, Angioli

مصطلحات موضوعية: he4 sensitivity, ca125 sensitivity, recurrent ovarian cancer, human epididymis protein 4

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22875782; info:eu-repo/semantics/altIdentifier/wos/WOS:000311201500031; volume:33; issue:6; firstpage:2117; lastpage:2123; numberofpages:7; journal:TUMOR BIOLOGY; http://hdl.handle.net/11573/646614Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85027936086

الإتاحة: https://doi.org/10.1007/s13277-012-0471-7Test
http://hdl.handle.net/11573/646614Test

المؤلفون: Pierluigi Benedetti-Panici, Patrizio Damiani, Stella Capriglione, Alessia Aloisi, Roberto Montera, Francesco Plotti, Roberto Angioli, Ludovico Muzii, Giuseppe Scaletta, Corrado Terranova

المصدر: Scopus-Elsevier

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, endocrine system diseases, Adolescent, Enzyme-Linked Immunosorbent Assay, Gastroenterology, Sensitivity and Specificity, he4 sensitivity, ca125 sensitivity, recurrent ovarian cancer, human epididymis protein 4, Young Adult, WAP Four-Disulfide Core Domain Protein 2, Adnexa Uteri, Statistical significance, Internal medicine, medicine, Biomarkers, Tumor, Humans, Prospective Studies, Cystadenocarcinoma, Prospective cohort study, Aged, Neoplasm Staging, Aged, 80 and over, Ovarian Neoplasms, business.industry, Case-control study, Proteins, General Medicine, Middle Aged, medicine.disease, Prognosis, female genital diseases and pregnancy complications, Cystadenocarcinoma, Serous, Endometrial Neoplasms, CA-125 Antigen, Case-Control Studies, Biomarker (medicine), Adenocarcinoma, Female, Neoplasm Grading, Neoplasm Recurrence, Local, Ovarian cancer, business, Progressive disease, Adenocarcinoma, Clear Cell, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a4e5a348a32d63633ca7779f01f4a5Test
http://hdl.handle.net/11573/646614Test